Taro Pharmaceutical Industries Ltd. TARO
42.98 0.00 (+0.00%)
Jun 21, 2024, 3:59 PM EDT
42.94 Day range 42.98
52-week range unavailable
Revenue & Expenses
Latest period ending Mar 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 | FY 2020 Mar 31, 2020 |
|---|---|---|---|---|---|
| 629.18M | 572.95M | 561.35M | 548.97M | 644.77M | |
| 304.96M | 268.32M | 293.12M | 296.66M | 399.73M | |
| 21.48M | 17.71M | 67.69M | -410.88M | 249.55M | |
| 53.87M | 25.45M | 58.27M | -386.65M | 244.24M | |
| 1.43 | 0.68 | 1.55 | -10.12 | 6.35 |
Balance sheet
| Fiscal year | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 | FY 2020 Mar 31, 2020 |
|---|---|---|---|---|---|
| 362.91M | 154.50M | 251.13M | 605.18M | 513.35M | |
| 2.16B | 2.14B | 2.18B | 2.41B | 2.34B | |
| 369.06M | 404.65M | 464.92M | 711.42M | 231.49M | |
| 1.79B | 1.73B | 1.71B | 1.70B | 2.10B |
Cash flow
| Fiscal year | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 | FY 2020 Mar 31, 2020 |
|---|---|---|---|---|---|
| 124.56M | 31.75M | -158.70M | 45.77M | 271.61M | |
| 84.34M | -125.56M | -170.58M | 67.74M | -298.16M | |
| -53.97M | -17.55M | -11.80M | -16.99M | -26.63M | |
| 208.41M | -96.64M | -354.04M | 91.82M | -54.10M |